LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,662,257 | -3.1% | 590,470 | -0.4% | 0.02% | 0.0% |
| Q2 2023 | $40,935,825 | +60.3% | 593,015 | +12.0% | 0.02% | +64.3% |
| Q1 2023 | $25,537,842 | +0.6% | 529,611 | +4.1% | 0.01% | -12.5% |
| Q4 2022 | $25,380,951 | +23.8% | 508,589 | +1.1% | 0.02% | +14.3% |
| Q3 2022 | $20,501,497 | -25.2% | 503,010 | +0.9% | 0.01% | -26.3% |
| Q2 2022 | $27,391,030 | +60.0% | 498,282 | +5.8% | 0.02% | +72.7% |
| Q1 2022 | $17,116,213 | +42.4% | 471,002 | +88.5% | 0.01% | +57.1% |
| Q4 2021 | $12,022,000 | -27.8% | 249,868 | -24.1% | 0.01% | -50.0% |
| Q3 2021 | $16,653,000 | +23.2% | 329,368 | 0.0% | 0.01% | +27.3% |
| Q2 2021 | $13,521,000 | +41.5% | 329,368 | 0.0% | 0.01% | +37.5% |
| Q1 2021 | $9,558,000 | – | 329,368 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |